Food and Drug Administration – Page 7

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

By Pam Belluck

Decisions and Verdicts Food and Drug Administration Justice Department Opioids and Opiates OxyContin (Drug) Purdue Pharma Sackler Family Suits and Litigation (Civil) Supreme Court (US)

Supreme Court Rejects Liability Shield at Center of Purdue Pharma Settlement

The liability shield would have protected members of the Sackler family from civil claims related to the opioid epidemic.

By Abbie VanSickle

Airlines and Airplanes Allergies Americans With Disabilities Act Celiac Disease Content Type: Service Diet and Nutrition Epinephrine (Drug) Federal Aviation Administration Food and Drug Administration Gluten Nuts Peanuts Seafood Travel and Vacations

How to Travel Safely if You Have Food Allergies

Airlines, restaurants and hotels are all making travel easier for people with sensitivities to foods like peanuts, wheat and milk, but it’s still critical to be your own advocate.

By Lisa McCarty

Alzheimer's Disease Biogen Inc Brain Clinical Trials donanemab Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory United States your-feed-healthcare your-feed-science

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

By Gina Kolata and Pam Belluck

mosaec